organization · Reporting owner

DANAHER CORP /DE/

Disclosed activity across 7 companies

Tapewire entity: 2871
SEC CIK: 0000313616

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
TEKTRONIX INCTEK · Entity 17224	10% owner	November 15, 2007	November 21, 2007

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TEKTRONIX INC

Report date November 15, 2007 · Filed November 21, 2007

Jointly reported with Raven Acquisition Corp.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock w/ Associated Preferred Shares Purchase RtsSEC Table I · non-derivative	IndirectBy Raven Acquisition Corp.	69,094,604	Reported balance Holding disclosure · report date 2007-11-15 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 69,094,604 F1: Common Stock of Tektronix, Inc. and associated Series B No Par Preferred Shares Purchase Rights F2: According to the depositary for the tender offer for the outstanding shares and associated preferred shares purchase rights of Tektronix, Inc. by Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation, 63,536,271 shares (excluding shares tendered pursuant to guaranteed delivery procedures) were validly tendered and not withdrawn prior to the expiration of the offer on November 15, 2007 at 11:59 p.m., New York City time. F3: The subsequent offering period for the tender offer expired at 11:59 p.m., New York City time, on November 20, 2007. When combined with the shares validly tendered into the subsequent offering period, according to the depositary, an aggregate of approximately 69,094,604 shares (excluding shares that had previously been tendered pursuant to guaranteed delivery procedures but were not actually delivered) were validly tendered into, and not withdrawn from, the offer, representing over 90% of the outstanding shares. Raven Acquisition Corp. has accepted for payment and purchased all validly tendered shares. F4: Shares are held by Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation. JOINT FILER INFORMATION Title of Securities: Common Stock of Tektronix, Inc. (TEK) and associated Series B No Par Preferred Shares Purchase Rights Designated Filer: Danaher Corporation, a Delaware corporation Other Joint Filer: Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation c/o Danaher Corporation 2099 Pennsylvania Avenue, NW 12th Floor Washington, DC 20006 (202) 828-0850 Date of event requiring statement: November 15, 2007

Filing footnotes · ownership attribution and instrument terms

F1: Common Stock of Tektronix, Inc. and associated Series B No Par Preferred Shares Purchase Rights

F2: According to the depositary for the tender offer for the outstanding shares and associated preferred shares purchase rights of Tektronix, Inc. by Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation, 63,536,271 shares (excluding shares tendered pursuant to guaranteed delivery procedures) were validly tendered and not withdrawn prior to the expiration of the offer on November 15, 2007 at 11:59 p.m., New York City time.

F3: The subsequent offering period for the tender offer expired at 11:59 p.m., New York City time, on November 20, 2007. When combined with the shares validly tendered into the subsequent offering period, according to the depositary, an aggregate of approximately 69,094,604 shares (excluding shares that had previously been tendered pursuant to guaranteed delivery procedures but were not actually delivered) were validly tendered into, and not withdrawn from, the offer, representing over 90% of the outstanding shares. Raven Acquisition Corp. has accepted for payment and purchased all validly tendered shares.

F4: Shares are held by Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation. JOINT FILER INFORMATION Title of Securities: Common Stock of Tektronix, Inc. (TEK) and associated Series B No Par Preferred Shares Purchase Rights Designated Filer: Danaher Corporation, a Delaware corporation Other Joint Filer: Raven Acquisition Corp., an Oregon corporation and indirect wholly owned subsidiary of Danaher Corporation c/o Danaher Corporation 2099 Pennsylvania Avenue, NW 12th Floor Washington, DC 20006 (202) 828-0850 Date of event requiring statement: November 15, 2007

Past disclosures · reporting ended (6)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ALIGN TECHNOLOGY INC

Report date November 13, 2013 · Filed November 14, 2013

Section 16 reporting ended · disclosed 2013-11-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
COMMON STOCKSEC Table I · non-derivative	Direct	3,837,132	Reported balance After 2013-11-13 transaction · row 1 1 source row Row 1 · 2013-11-13 · Sale · Disposed 4,600,000 · Balance 3,837,132

Envista Holdings Corp

Report date December 18, 2019 · Filed December 18, 2019

Section 16 reporting ended · disclosed 2019-12-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-12-18 transaction · row 1 1 source row Row 1 · 2019-12-18 · Other · Disposed 127,868,000 · Balance 0 F1: Danaher Corporation ("Danaher") disposed of 127,868,000 shares of Issuer common stock in exchange for 22,921,984 shares of Danaher common stock pursuant to a registered exchange offer to holders of shares of Danaher common stock. The final exchange ratio was 5.5784 shares of Issuer common stock per share of Danaher common stock accepted in the exchange offer.

Filing footnotes · ownership attribution and instrument terms

F1: Danaher Corporation ("Danaher") disposed of 127,868,000 shares of Issuer common stock in exchange for 22,921,984 shares of Danaher common stock pursuant to a registered exchange offer to holders of shares of Danaher common stock. The final exchange ratio was 5.5784 shares of Issuer common stock per share of Danaher common stock accepted in the exchange offer.

Fortive Corp

Report date July 02, 2016 · Filed July 05, 2016

Section 16 reporting ended · disclosed 2016-07-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2016-07-02 transaction · row 1 1 source row Row 1 · 2016-07-02 · Other · Disposed 345,237,561 · Balance 0 F1: The transaction reported on this Form relates to the distribution to the Reporting Person's stockholders of shares of Issuer's common stock held by the Reporting Person, effective as of July 2, 2016 (the "Distribution"). To effect the Distribution, the issued and outstanding common stock of the Issuer, consisting of 100 shares of common stock prior to the Distribution, was recapitalized into 345,237,561 shares of the Issuer's common stock and distributed, by means of a pro rata dividend, to the holders of the Reporting Person's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of the Reporting Person).

Filing footnotes · ownership attribution and instrument terms

F1: The transaction reported on this Form relates to the distribution to the Reporting Person's stockholders of shares of Issuer's common stock held by the Reporting Person, effective as of July 2, 2016 (the "Distribution"). To effect the Distribution, the issued and outstanding common stock of the Issuer, consisting of 100 shares of common stock prior to the Distribution, was recapitalized into 345,237,561 shares of the Issuer's common stock and distributed, by means of a pro rata dividend, to the holders of the Reporting Person's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of the Reporting Person).

KEITHLEY INSTRUMENTS INC

Report date December 08, 2010 · Filed December 09, 2010

Jointly reported with Aegean Acquisition Corp.

Section 16 reporting ended · disclosed 2010-12-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common SharesSEC Table II · derivative / convertible security	IndirectSee Note	0	Reported balance After 2010-12-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2010-12-08 · Other · Disposed 0 · Balance 0 F1: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher.

Telesis Bio Inc.

Report date June 22, 2021 · Filed June 24, 2021

Jointly reported with Danaher Innovation Center LLC

Section 16 reporting ended · disclosed 2021-06-24. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Danaher Innovation Center LLC	2,294,157	Reported balance After 2021-06-22 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-06-22 · Conversion · Acquired 2,294,157 · Balance 2,294,157 F1: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.
Series A Preferred StockSEC Table II · derivative / convertible security	IndirectBy Danaher Innovation Center LLC	0	Reported balance After 2021-06-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-06-22 · Conversion · Disposed 1,751,999 · Balance 0 F1: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.
Series A-1 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Danaher Innovation Center LLC	0	Reported balance After 2021-06-22 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-06-22 · Conversion · Disposed 542,158 · Balance 0 F1: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date.

F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.

Veralto Corp

Report date September 30, 2023 · Filed October 03, 2023

Section 16 reporting ended · disclosed 2023-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2023-09-30 transaction · row 1 1 source row Row 1 · 2023-09-30 · Other · Disposed 246,291,342 · Balance 0 F1: The transaction reported on this Form relates to the distribution on September 30, 2023 to holders of Danaher Corporation's ("Danaher") common stock of all of the issued and outstanding shares of common stock of Veralto Corporation (the "Company") held by Danaher (the "Distribution"). To effect the Distribution, 246,291,342 shares of Veralto common stock were distributed, by means of a pro rata dividend, to the holders of Danaher's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of Danaher). F2: Prior to the Distribution, solely as a result of a 2,462,913.42-for-1 stock split that was effected pursuant to a Certificate of Amendment to the Certificate of Incorporation of Veralto on September 29, 2023, the 100 shares of Veralto common stock previously owned by Danaher were split into and became an aggregate of 246,291,342 shares, in a transaction exempt from reporting pursuant to Rule 16a-9 under the Securities Exchange Act of 1934.

Filing footnotes · ownership attribution and instrument terms

F1: The transaction reported on this Form relates to the distribution on September 30, 2023 to holders of Danaher Corporation's ("Danaher") common stock of all of the issued and outstanding shares of common stock of Veralto Corporation (the "Company") held by Danaher (the "Distribution"). To effect the Distribution, 246,291,342 shares of Veralto common stock were distributed, by means of a pro rata dividend, to the holders of Danaher's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of Danaher).

F2: Prior to the Distribution, solely as a result of a 2,462,913.42-for-1 stock split that was effected pursuant to a Certificate of Amendment to the Certificate of Incorporation of Veralto on September 29, 2023, the 100 shares of Veralto common stock previously owned by Danaher were split into and became an aggregate of 246,291,342 shares, in a transaction exempt from reporting pursuant to Rule 16a-9 under the Securities Exchange Act of 1934.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2023 Filed Oct 3, 2023 00:10 UTC	Veralto Corp VLTO · Entity 3203	OtherCommon Stock	246,291,342	$0.00	$0.00	Disclosure SEC source: 0001209191-23-051257 · doc4.xml · nonDerivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: The transaction reported on this Form relates to the distribution on September 30, 2023 to holders of Danaher Corporation's ("Danaher") common stock of all of the issued and outstanding shares of common stock of Veralto Corporation (the "Company") held by Danaher (the "Distribution"). To effect the Distribution, 246,291,342 shares of Veralto common stock were distributed, by means of a pro rata dividend, to the holders of Danaher's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of Danaher). F2 · shares: Prior to the Distribution, solely as a result of a 2,462,913.42-for-1 stock split that was effected pursuant to a Certificate of Amendment to the Certificate of Incorporation of Veralto on September 29, 2023, the 100 shares of Veralto common stock previously owned by Danaher were split into and became an aggregate of 246,291,342 shares, in a transaction exempt from reporting pursuant to Rule 16a-9 under the Securities Exchange Act of 1934. Read SEC document
June 22, 2021 Filed Jun 24, 2021 20:51 UTC	Telesis Bio Inc. DNAY · Entity 15606	ConversionSeries A-1 Preferred Stock · Derivative	542,158	$0.00	$0.00	Disclosure SEC source: 0001209191-21-043061 · doc4.xml · derivative · entry 3 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner Danaher Innovation Center LLC · CIK 0001868059 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Danaher Innovation Center LLC Disclosed balance after: 0 Underlying: Common Stock · 542,158 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · price: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2 · ownership.nature: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037. Read SEC document
June 22, 2021 Filed Jun 24, 2021 20:51 UTC	Telesis Bio Inc. DNAY · Entity 15606	ConversionSeries A Preferred Stock · Derivative	1,751,999	$0.00	$0.00	Disclosure SEC source: 0001209191-21-043061 · doc4.xml · derivative · entry 2 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner Danaher Innovation Center LLC · CIK 0001868059 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Danaher Innovation Center LLC Disclosed balance after: 0 Underlying: Common Stock · 1,751,999 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · price: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2 · ownership.nature: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037. Read SEC document
June 22, 2021 Filed Jun 24, 2021 20:51 UTC	Telesis Bio Inc. DNAY · Entity 15606	ConversionCommon Stock	2,294,157	$0.00	$0.00	Disclosure SEC source: 0001209191-21-043061 · doc4.xml · nonDerivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner Danaher Innovation Center LLC · CIK 0001868059 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Danaher Innovation Center LLC Disclosed balance after: 2,294,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date. F2 · ownership.nature: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037. Read SEC document
December 18, 2019 Filed Dec 18, 2019 13:58 UTC	Envista Holdings Corp NVST · Entity 4007	OtherCommon Stock	127,868,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-19-029511 · doc4.xml · nonDerivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Danaher Corporation ("Danaher") disposed of 127,868,000 shares of Issuer common stock in exchange for 22,921,984 shares of Danaher common stock pursuant to a registered exchange offer to holders of shares of Danaher common stock. The final exchange ratio was 5.5784 shares of Issuer common stock per share of Danaher common stock accepted in the exchange offer. Read SEC document
July 02, 2016 Filed Jul 5, 2016 20:34 UTC	Fortive Corp FTV · Entity 3303	OtherCommon Stock	345,237,561	$0.00	$0.00	Disclosure SEC source: 0000899243-16-024318 · doc4.xml · nonDerivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction reported on this Form relates to the distribution to the Reporting Person's stockholders of shares of Issuer's common stock held by the Reporting Person, effective as of July 2, 2016 (the "Distribution"). To effect the Distribution, the issued and outstanding common stock of the Issuer, consisting of 100 shares of common stock prior to the Distribution, was recapitalized into 345,237,561 shares of the Issuer's common stock and distributed, by means of a pro rata dividend, to the holders of the Reporting Person's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of the Reporting Person). Read SEC document
November 13, 2013 Filed Nov 14, 2013 13:40 UTC	ALIGN TECHNOLOGY INC ALGN · Entity 3488	SaleCOMMON STOCK	4,600,000	$54.60	$251,160,000.00	Disclosure SEC source: 0001181431-13-058893 · rrd395388.xml · nonDerivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,837,132 Read SEC document
December 08, 2010 Filed Dec 9, 2010 16:36 UTC	KEITHLEY INSTRUMENTS INC KEI · Entity 16932	OtherClass B Common Shares · Derivative	0	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-10-059390 · doc4.xml · derivative · entry 1 DANAHER CORP /DE/ · CIK 0000313616 · 10% owner Aegean Acquisition Corp. · CIK 0001502907 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note Disclosed balance after: 0 Underlying: Common Shares · 0 shares Expires not disclosed F1 · security: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · derivative.exercise_price: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · shares: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · price: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · derivative.exercise_date: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · derivative.expiration_date: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · balance_after: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. F1 · ownership.nature: This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. ("Merger Sub" and together with Danaher Corporation, the "Reporting Persons") with and into the Issuer on December 8, 2010. In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.